Brief: Chugai Pharmaceutical says lawsuit on patent infringement concerning herceptin® injection

Chugai Pharmaceutical

12/10/2018 06:09

Oct 12 (Reuters) - Chugai Pharmaceutical Co Ltd  4519.T  
    
    * Says the company announced that it has filed a lawsuit to
the
Tokyo District Court as of October 12, and has also filed a
petition for provisional disposition order, demanding the
suspension of manufacturing and distribution of the biosimilar
of anti-HER2 monoclonal antibody Herceptin® Injection 60 and 150
(Herceptin® Injection), against Pfizer Japan Inc., the marketing
authorization holder of the biosimilar of Herceptin® Injection,
citing such party's infringement of the application patent owned
by Genentech, a member of the Roche group, as the ground

    
    Source text in Japanese:https://goo.gl/pK4HuN
    Further company coverage: 4519.T 

 (Beijing Headline News)
 ((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111;
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))